Long QT syndrome can be a silent threat. Although not all patients with congenital long QT syndrome develop symptoms, there is potential for dangerous arrhythmia that can cause sudden cardiac death. Can and should genetic testing guide clinicians in diagnosing and treating this condition? Dr. Dan Roden, professor of medicine and pharmacology and assistant vice-chancellor for personalized medicine at Vanderbilt University School of Medicine, says the concept of personalized medicine goes beyond genetics; it is also about meeting a patient's goals and individual needs. How can genetic testing help physicians decide which medical therapy might be most appropriate for each patient? Dr. Janet Wright hosts.
Genetic Testing for Long QT Syndrome
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Long QT syndrome can be a silent threat. Although not all patients with congenital long QT syndrome develop symptoms, there is potential for dangerous arrhythmia that can cause sudden cardiac death. Can and should genetic testing guide clinicians in diagnosing and treating this condition? Dr. Dan Roden, professor of medicine and pharmacology and assistant vice-chancellor for personalized medicine at Vanderbilt University School of Medicine, says the concept of personalized medicine goes beyond genetics; it is also about meeting a patient's goals and individual needs. How can genetic testing help physicians decide which medical therapy might be most appropriate for each patient? Dr. Janet Wright hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
HF Management for Patients with Comorbid Conditions
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?